Dual-modified liposome codelivery of doxorubicin and vincristine improve targeting and therapeutic efficacy of glioma-Reference-Cited by-同舟云学术

Dual-modified liposome codelivery of doxorubicin and vincristine improve targeting and therapeutic efficacy of glioma

Published:2017-01-01 Issue:1 Volume:24 Page:1045-1055
ISSN:1071-7544
Container-title:Drug Delivery
language:en
Short-container-title:Drug Delivery

Author:

Zhang Yue¹²,Zhai Meifang¹³,Chen Zhijiang¹²,Han Xiaoyang⁴,Yu Fanglin¹,Li Zhiping¹,Xie Xiangyang⁵,Han Cuiyan⁶,Yu Lian³,Yang Yang¹,Mei Xingguo¹

Affiliation:

1. State key Laboratory of Toxicology and Medical Countermeasure, Department of Pharmaceutics, Beijing Institute of Pharmacology and Toxicology, Beijing, PR China;

2. Hubei University of Science and Technology, Xianning, PR China;

3. Jiamusi University, Jiamusi, PR China;

4. Outpatient Department of Beijing Space City, Aerospace Systems Divison, PLA Strategic Support Force, Beijing, PR China;

5. Department of Pharmacy, Wuhan General Hospital of the Chinese People’s Liberation Army, Wuhan, PR China;

6. School of Pharmacy, Qiqihar Medical University, Qiqihar, PR China

Funder

Beijing Science and Technology New Star

Beijing Natural Science Foundation

Natural Science Foundation of Hubei Province

Health & Family Planning Commission of Hubei Province

Nature Science Foundation of Heilongjiang Province

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,General Medicine

Link

https://tandfonline.com/doi/pdf/10.1080/10717544.2017.1344334

Reference36 articles.

1. Treatment of intermediate risk rhabdomyosarcoma and undifferentiated sarcoma with alternating cycles of vincristine/doxorubicin/cyclophosphamide and etoposide/ifosfamide

2. Quantification of Doxorubicin and metabolites in rat plasma and small volume tissue samples by liquid chromatography/electrospray tandem mass spectroscopy

3. Cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy and radiotherapy for stage I intermediate or high grade non-Hodgkin's lymphomas: results of a strategy that adapts radiotherapy dose to the response after chemotherapy

4. Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis

5. Turbiscan Lab® Expert analysis of the stability of ethosomes® and ultradeformable liposomes containing a bilayer fluidizing agent

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polypeptides-Based Nanocarriers in Tumor Therapy;Pharmaceutics;2024-09-10

2. CNS delivery of targeted protein degraders;Journal of Controlled Release;2024-08

3. Liposomal Nanomaterials: A Rising Star in Glioma Treatment;International Journal of Nanomedicine;2024-07

4. New Transferrin Receptor-Targeted Peptide–Doxorubicin Conjugates: Synthesis and In Vitro Antitumor Activity;Molecules;2024-04-12

5. A dual drug-loaded tumor vasculature-targeting liposome for tumor vasculature disruption and hypoxia-enhanced chemotherapy;Chinese Chemical Letters;2024-03